Skip to main content

February 2012, Vol 2, No 1

FDA-Approved Medications Used for Supportive Care in Cancer Treatment

February 2012, Vol 2, No 1

Seasons of Survival

By Irit Ben-Aharon, MD, PhD; Lindsay Haines, BA; Kenneth Miller, MD

February 2012, Vol 2, No 1

An Emerging Breed of Super Administrator

By Dawn Holcombe, MBA, FACMPE, ACHE

From the Editor

February 2012, Vol 2, No 1

Ultimate Goal in Selling a Practice Is to Reach a Collaborative Agreement

By Wayne Kuznar

Cancer Center Business Summit Highlights

February 2012, Vol 2, No 1

Oncology Practice Trends: Operating Margins Will Continue to Decline, Alternatives to Fee-for-Service Gain Traction

By Wayne Kuznar

Cancer Center Business Summit Highlights

February 2012, Vol 2, No 1

An Array of Compensation Models to Align Oncologists’ and Hospitals’ Interests

By Wayne Kuznar

Cancer Center Business Summit Highlights

February 2012, Vol 2, No 1

Know the Federal Laws that Apply to Buying and Selling Oncology Practices

By Wayne Kuznar

Cancer Center Business Summit Highlights

February 2012, Vol 2, No 1

Maintaining Your Records: In What Form and for How Long?

By Jennifer Kirschenbaum, Esq

February 2012, Vol 2, No 1

ACO Final Rule: Enough to Entice the Oncology Team?

By Sydney Abbott, JD

February 2012, Vol 2, No 1

The result of the November 17, 2011, hyperpartisan Congress is policymaking stuck firmly in division and gridlock. Many healthcare issues remain in contention, including key components of the Patient Protection and Affordable Care Act (ACA). Read More ›